Duchenne Research Fund
  • Home
  • Duchenne facts
  • Our story
  • Our projects
  • News
  • Get involved
    • Get involved
    • Gallery
  • Contact
  • Donate
Select Page

Landmark day for Duchenne as Givinostat approved for use in England

8 May 2026

On a landmark day for the Duchenne muscular dystrophy community, we are delighted to share that the National Institute for Health and Care Excellence (NICE) has recommended the treatment givinostat (brand name Duvyzat) for use on the NHS in England. In final draft...

Most recent:

  • Duchenne Care UK podcast series launched
  • Duchenne Care UK orthopaedic guideline recognised by NICE
  • Landmark day for Duchenne as Givinostat approved for use in England
  • Solid doses first patient on Phase 3 trial
  • Duchenne Care UK launches psychosocial guidelines

More about our projects:

administrative post award clinical post complementary current drug development early stage facility gene therapy past post project research standards of care

Jump to:

  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Facebook
  • Twitter
  • Instagram
Copyright © 2026 The Duchenne Research Fund. Registered Charity No. 1119068. Website by Sheli Rodney